| 1 |
CLINICAL AND LABORATORY STANDARDS INSTITUTE. CLSI EP32-Ed2 Implementation of metrological traceability in laboratory medicine[S]. Wayne: Clinical and Laboratory Standards Institute, 2025.
|
| 2 |
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION. ISO 17511: 2020 In vitro diagnostic medical devices-Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples[S]. Geneva: International Organization for Standardization, 2020.
|
| 3 |
周伟燕, 刘庆香, 刘珍妮, 等. 计量溯源性和临床检验参考系统[J]. 临床检验杂志, 2020(10): 38.
|
| 4 |
杜利军, 张乔轩, 汤君翊, 等. 蛋白类血清肿瘤标志物检测标准化现状[J]. 中华检验医学杂志, 2019, 42(1): 10-13.
|
| 5 |
中国计量科学研究院. 北京市医疗器械检验研究院. 重组人血清淀粉样蛋白A的同位素稀释质谱定量方法研究[J]. 计量科学与技术, 2025, 69(3): 56-62.
|
| 6 |
国家市场监督管理总局, 国家标准化管理委员会. GB/T 44672-2024 体外诊断医疗器械 建立校准物和人体样品赋值计量学溯源性的国际一致化方案的要求[S]. 北京:中国标准出版社, 2024.
|
| 7 |
中华人民共和国国家卫生健康委员会. WS/T 403-2024 临床化学检验常用项目分析质量标准[S]. 北京:中国标准出版社, 2024.
|
| 8 |
CLINICAL AND LABORATORY STANDARDS INSTITUTE. CLSI EP05-A3 Evaluation of Precision of Quantitative Measurement Procedures: Approved Guideline-Third Edition[S]. Wayne: Clinical and Laboratory Standards Institute, 2014.
|
| 9 |
BEASTALL G H. Traceability in laboratory medicine: What is it and why is it important for patients?[J]. EJIFCC, 2018, 29(4): 242-247.
|
| 10 |
中华人民共和国国家卫生健康委员会. WS/T 406-2024 临床血液检验常用项目分析质量标准[S]. 北京:中国标准出版社, 2024.
|
| 11 |
DANILENKO U, VESPER H W, MYERS G L,et al. An updated protocol based on CLSI document C37 for preparation of off-the-clot serum from individual units for use alone or to prepare commutable pooled serum reference materials[J]. Clinical chemistry and laboratory medicine, 2020, 58(3): 368-374.
|
| 12 |
AMERICAN SOCIETY FOR CLINICAL LABORATORY SCIENCE. Value of clinical laboratory services in health care[J]. Clinical laboratory science: Journal of the American Society for Medical Technology, 2013, 26(1): 8-9.
|
| 13 |
PLEBANI M. Harmonization in laboratory medicine: Requests, samples, measurements and reports[J]. Critical reviews in clinical laboratory sciences, 2016, 53(3): 184-196.
|
| 14 |
HOERGER T J, WITTENBORN J S, YOUNG W. A cost-benefit analysis of lipid standardization in the United States[J]. Preventing chronic disease, 2011, 8(6): A136.
|
| 15 |
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION. ISO 21151: 2020 In vitro diagnostic medical devices-Requirements for international harmonisation protocols establishing metrological traceability of values assigned to calibrators and human samples[S]. Geneva: International Organization for Standardization, 2020.
|
| 16 |
XU K, BAI X, SUN Y, et al. The invisible bridge: How harmonisation closes the gap between impossible standardization and clinical necessity[J]. Clinica chimica acta; international journal of clinical chemistry, 2026, 578: 120516.
|
| 17 |
THIENPONT L M, VAN UYTFANGHE K, BEASTALL G, et al. Report of the ifcc working group for standardization of thyroid function tests; part 1: Thyroid-stimulating hormone[J]. Clinical chemistry, 2010, 56(6): 902-911.
|
| 18 |
PANTEGHINI M. Traceability, reference systems and result comparability[J]. The clinical biochemist, 2007, 28(3): 97-104.
|
| 19 |
INFUSINO I, MAURO P. Standardization in clinical enzymology[J]. EJIFCC, 2009, 20(3): 141-147.
|
| 20 |
中华人民共和国国家卫生健康委员会. WS/T 356-2024 参考物质互换性评估指南[S]. 北京:中国标准出版社, 2024.
|
| 21 |
国家市场监督管理总局. JJF 2155-2024 检验医学标准物质互换性评估要求[S]. 北京:中国计量出版社, 2024.
|
| 22 |
INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE. IFCC Guidelines for metrological traceability in laboratory medicine[Z]. Milan: International Federation of Clinical Chemistry and Laboratory Medicine, 2024.
|